Acerta PharmaListed
acerta-pharma.combiotech_life_sciences
Acerta Pharma is a European R&D centre of the AstraZeneca Group, dedicated to the discovery and development of novel innovative medicines for the treatment of haematological malig…
Portfolio
A closer look at the companies associated with this firm. Verified team members can update the portfolio after signing in.
This is the portfolio currently shown on the public firm page.
Acerta Pharma is a European R&D centre of the AstraZeneca Group, dedicated to the discovery and development of novel innovative medicines for the treatment of haematological malig…
Adaptimmune focuses on designing and delivering novel cancer immunotherapy products, utilizing the body’s own T-cells to target and destroy cancer. They have developed a proprieta…
Adverum Biotechnologies is a clinical-stage company focused on developing gene therapies for ocular diseases, aiming to establish gene therapy as a new standard of care to restore…
Aerie Pharmaceuticals was an American clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapies for the treatment of patients…
Allogene Therapeutics is a clinical-stage biotechnology company focused on pioneering the development of investigational allogeneic chimeric antigen receptor T cell (AlloCAR T) pr…
Amarin is a global pharmaceutical company committed to providing cost-effective cardiovascular care to high-risk adult cardiovascular patients, focusing on reducing the cardiovasc…
Amicus Therapeutics is a biotechnology company focused on developing medicines for people living with genetically defined conditions, particularly in the rare disease sector.
Amylyx Pharmaceuticals is a clinical-stage pharmaceutical company focused on developing novel therapies for diseases with high unmet needs, including amyotrophic lateral sclerosis…
Apellis Pharmaceuticals is a biotechnology company focused on developing innovative therapies for patients with serious diseases driven by the complement system. They have pioneer…
Argenx is a biotechnology company focused on developing innovative immunology solutions, particularly through antibody engineering and clinical trials to treat severe autoimmune d…
Ascendis Pharma is a global biopharmaceutical company committed to making a meaningful difference in patients’ lives through innovative therapies developed using their TransCon te…
Assembly Bio is an ambitious biopharmaceutical company with cutting-edge therapeutic candidates capable of improving the lives of millions living with devastating viral and liver…
Athenex is a global specialty oncology pharmaceutical company focused on the development and commercialization of next generation therapies for cancer diseases and supportive ther…
Avadel Pharmaceuticals Plc is a biopharmaceutical company that focuses on the development of products for the treatment of narcolepsy. Its marketed product Lumryz is an FDA-approv…
Avidity Biosciences is focused on delivering a new class of targeted RNA therapeutics using its proprietary Antibody Oligonucleotide Conjugates (AOC™) platform, primarily targetin…
Bellicum Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel cellular immunotherapies for various forms of…
Catalyst Biosciences is a research and clinical development biopharmaceutical company focused on developing protease therapeutics to address unmet medical needs in disorders of th…
Constellation Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel therapeutics that selectively modulate gene expression to address serious unmet medica…
Corvus is a clinical-stage biopharmaceutical company developing novel therapies with the potential to significantly improve the treatment of immune diseases and cancer. Our lead p…
CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform.
We are a clinical-stage biopharmaceutical company focused on developing and providing access to innovative therapies for patients with liver and other chronic diseases with high u…
Design Therapeutics is a biopharmaceutical company advancing novel, small molecule therapeutic candidates designed to bring functional cures to serious genetic diseases with long-…
DICE Therapeutics is a biopharmaceutical company leveraging its proprietary DELSCAPE technology platform to develop novel oral therapeutic candidates for chronic diseases in immun…
Fennec Pharmaceuticals Inc. is a commercial stage specialty pharmaceutical company focused on the development of PEDMARK® (sodium thiosulfate injection), the first FDA-approved th…
Details are not available yet. The company remains listed.
Horizonte Therapeutics is a biopharmaceutical company focused on researching, developing, and commercializing medicines that address critical needs for individuals affected by rar…
Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill (AP) platform technology. The company's Accordion Pi…
Intellia Therapeutics is a biotechnology company focused on using CRISPR technology for gene editing. The company is involved in developing treatments for genetic diseases.
Details are not available yet. The company remains listed.
Iovance Biotherapeutics is pioneering a transformational approach to treating cancer by harnessing the ability of the human immune system to recognize and attack diverse cancer ce…
IVERIC bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical ne…
Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company focused on pioneering novel cancer therapies, particularly through the use of Selective Inhibitor of Nucl…
Krystal Biotech is a biotechnology company focused on developing and commercializing genetic medicines for patients with rare diseases. The company’s first commercial product, VYJ…
Kura Oncology is focused on the development of precision medicines for the treatment of cancer, utilizing innovative approaches to overcome resistance and identify novel biomarker…
Kymera is a clinical-stage biotechnology company focused on developing innovative medicines through targeted protein degradation, aiming to address critical health problems and im…
Madrigal Pharmaceuticals is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disea…
Marinus Pharmaceuticals is dedicated to developing innovative treatments for patients with rare diseases, focusing on rare metabolic and rare neurological conditions.
Merus is focused on discovering and developing new treatments for cancer using their Multiclonics® Platform.
Mirati Therapeutics, a clinical-stage oncology company, focuses on the research and development of novel therapeutics targeting the genetic and immunological drivers of cancer. Th…
Monte Rosa Therapeutics is focused on developing molecular glue degraders (MGDs) that target undruggable proteins for therapeutic purposes, particularly in immunology and inflamma…
NantKwest, Inc. is an immunotherapy firm focused on developing therapies using natural killer cells for cancer treatment.
Nuvalent is focused on creating precisely targeted therapies for patients with cancer, utilizing deep expertise in chemistry and structure-based drug discovery.
Olema is a clinical-stage biopharmaceutical company focused on transforming the metastatic breast cancer treatment paradigm and improving outcomes for patients living with breast…
Ottimo Pharma is an innovative, clinical-stage, biotech company developing one-of-a-kind PD-1/VEGFR2 dual-paratopic antibodies to extend the lives of patients living with cancer.
Outlook Therapeutics is a biopharmaceutical company focused on the development and commercialization of LYTENAVA™ (bevacizumab-vikg) for the treatment of retinal diseases, includi…
PMV Pharmaceuticals is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies that target p53 mutations. The company foc…
Praxis Precision Medicines is a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, translating insights from genetic epilepsi…
Developing therapies targeting protein misfolding diseases.
Rocket Pharma is focused on developing gene therapies for rare diseases, particularly those affecting the heart and blood, such as Danon Disease and Arrhythmogenic Cardiomyopathy.
Sarepta Therapeutics is a biotechnology company focused on developing innovative RNA-targeted therapeutics to treat rare diseases, particularly genetic disorders such as Duchenne…
Scorpion is a clinical-stage, precision oncology company developing transformational targeted therapies for patients with cancer. We have built proprietary and fully-integrated di…
Scribe is rewriting medicine with molecular engineering, focusing on creating safe and effective genetic medicines using CRISPR technology to treat cardiometabolic diseases.
Stemline Therapeutics is focused on the development and commercialization of novel oncology therapeutics, including targeted therapies for difficult-to-treat cancers.
Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company advancing innovative cancer therapies, including a menin inhibitor for R/R acute leukemia and a monoclonal a…
Tourmaline Bio is a late-stage clinical biotechnology company focused on developing transformative medicines for immune and inflammatory diseases.
Tricida Inc is a clinical-stage pharmaceutical company focused on discovering and developing novel non-absorbed therapies for renal, metabolic, and cardiovascular diseases, partic…
Trillium is a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, focusing on CD47 programs and SIRPα-Fc fusion proteins.
Vanqua Bio is a biopharmaceutical company focused on discovering and developing next-generation medicines for neurodegenerative diseases, particularly targeting glucocerebrosidase…
Vicebio is a biotech company focused on developing vaccines against life-threatening respiratory viral infections using its proprietary Molecular Clamp technology, which stabilize…
Viking Therapeutics is a clinical-stage biotechnology company advancing a next-generation portfolio of therapies for obesity and metabolic disease. We are developing treatments to…
Viveve Medical, Inc. is a women's intimate health company passionately committed to advancing new solutions to improve women's overall well-being and quality of life. The internat…
Vividion Therapeutics is focused on transforming patient care through small molecule therapeutics, utilizing chemoproteomics and covalent chemistry to target previously undrugged…
Whitehawk Therapeutics is an antibody drug conjugate (ADC)-focused oncology therapeutics company that employs an agile and pragmatic strategy to drug development. The company targ…
Xenon Pharmaceuticals is a biopharmaceutical company focused on neuroscience, developing treatments for epilepsy and depression. Its lead molecule is in Phase 3 trials.
Zealand Pharma is a biotechnology company focused on the discovery and development of innovative peptide-based medicines to treat diabetes and other serious diseases.
Developing best-in-class medicines to improve the lives of people with Thyroid Eye Disease and Graves’ Disease.
Hemab Therapeutics is focused on developing targeted therapies for bleeding disorders, including Glanzmann Thrombasthenia and Von Willebrand Disease, aiming to provide new treatme…